To explore the use of the CRISPR/Cas9 system to target Kv1.3 channel-encoding genes Kcna3 and elucidate the pathophysiological function mediated by Kv1.3 channels in Jurkat T cells. The first exon sgRNA of human Kcna3 in pX458-sgRNA recombinant vector was transferred into human Jurkat T cells via electroporation. T7EN1 digestion, Genomic PCR products and TA cloning sequencing, Western blot, and functional assays, such as electrophysiology, live-cell calcium imaging and ELISA were used to validate Kcna3 knockout effect in Jurkat T cells. The results of the sequencing analysis showed that the CRISPR/Cas9 recombinant plasmids pX458-sgRNA targeting Kcna3 were successfully constructed. The designed sgRNA2 can efficiently cleave genomic DNA. Kv1.3 protein expression could not be detected using Western blot analysis. Genomic PCR products and TA cloning sequencing showed the presence of Indel mutation. Whole-cell patch clamp experiments showed that Kv1.3 channel currents could not be recorded in Kcna3 knockout Jurkat T cells. Live-cell calcium imaging showed that the increase in free Ca2+ concentration in Kcna3 knockout Jurkat T cells was significantly lower than that in wild type Jurkat T cells. ELISA results showed that the IL-2 level of Kcna3 knockout Jurkat T cells was significantly decreased compared with that in wild-type Jurkat T cells ( P Kcna3 in Jurkat T cells using the CRISPR/Cas9 system strongly proved that Kv1.3 mediated the immune inflammatory response of Jurkat T cells, which provides a novel cell model for further study of the pathophysiological function of the Kv1.3 channel.
Read full abstract